Published in Mov Disord on January 01, 1998
Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial. J Neurol Neurosurg Psychiatry (2005) 1.59
Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease. J Adv Nurs (2011) 1.10
Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs Aging (2008) 1.08
Predictors of life satisfaction in stroke survivors and spousal caregivers after inpatient rehabilitation. Rehabil Nurs (2009) 1.02
Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. J Neurol (2005) 0.96
Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries. Qual Life Res (2009) 0.91
Quality of life in Parkinson's disease caregivers: the contribution of personality traits. Biomed Res Int (2013) 0.90
Single and dual task gait training in people with Parkinson's disease: a protocol for a randomised controlled trial. BMC Neurol (2011) 0.89
Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol (2005) 0.88
Predictors of caregiver burden in partners of patients with Parkinson's disease. Neurol Sci (2009) 0.87
The longitudinal and dyadic effects of mutuality on perceived stress for stroke survivors and their spousal caregivers. Aging Ment Health (2013) 0.87
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease. J Consult Clin Psychol (2012) 0.86
Health-related quality of life and strain in caregivers of Australians with Parkinson's disease: an observational study. BMC Neurol (2012) 0.82
Caregiving tasks and training interest of family caregivers of medically ill homebound older adults. J Aging Health (2009) 0.78
Parkinson's psychosis. Curr Treat Options Neurol (2010) 0.77
The study protocol of a cluster-randomised controlled trial of family-mediated personalised activities for nursing home residents with dementia. BMC Geriatr (2012) 0.77
Family caregivers' role implementation at different stages of dementia. Clin Interv Aging (2015) 0.77
Informal caregiving in Hematopoietic Blood and Marrow Transplant patients. Eur J Oncol Nurs (2011) 0.76
How does difficulty communicating affect the social relationships of older adults? An exploration using data from a national survey. J Commun Disord (2016) 0.76
Pharmacotherapy in the management of early Parkinson's disease: cost-effectiveness and patient acceptability. Clinicoecon Outcomes Res (2010) 0.75
Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses. Parkinsons Dis (2017) 0.75
The Relationship between the Experience of Hypomimia and Social Wellbeing in People with Parkinson's Disease and their Care Partners. J Parkinsons Dis (2016) 0.75
Associations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's Disease. Front Neurosci (2017) 0.75
The Roles of Dyadic Appraisal and Coping in Couples With Lung Cancer. J Fam Nurs (2016) 0.75
Self-care in Patient with Major Thalassemia: A Grounded Theory. J Caring Sci (2017) 0.75
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (1993) 10.36
Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature (1979) 6.10
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature (2001) 5.95
Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet (1995) 5.85
Successful small-bowel/liver transplantation. Lancet (1990) 4.85
Sonic hedgehog regulates growth and morphogenesis of the tooth. Development (2000) 4.71
Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science (1990) 4.01
Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology (1997) 3.68
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS (1999) 3.51
Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med (1997) 3.23
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A (1996) 3.07
Comparison of API and Minitek to Center for Disease Control methods for the biochemical characterization of anaerobes. J Clin Microbiol (1976) 2.93
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol (1999) 2.90
Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature (1980) 2.74
Excessive infant crying: a controlled study of mothers helping mothers. Pediatrics (1994) 2.72
De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology (2009) 2.53
Function and assembly of photosystem II: genetic and molecular analysis. Trends Biochem Sci (1988) 2.52
Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47
Genetic neutropenia in people of African origin. Lancet (1971) 2.40
Mutuality and preparedness as predictors of caregiver role strain. Res Nurs Health (1990) 2.29
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease. Neurology (1993) 2.16
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Vitreoretinal surgery after inadvertent globe penetration during local ocular anesthesia. Ophthalmology (1998) 2.09
The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol (2000) 2.08
AmpG, a signal transducer in chromosomal beta-lactamase induction. Mol Microbiol (1993) 2.06
Heat shock regulatory gene rpoH mRNA level increases after heat shock in Escherichia coli. J Bacteriol (1986) 2.04
Analysis of 1071 gift procedures--the case for a flexible approach to treatment. Lancet (1988) 2.03
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev Biol (2001) 1.98
Leukocyte and fibroblast interferon genes are located on human chromosome 9. Proc Natl Acad Sci U S A (1981) 1.98
Evaluation of the short-term impact of counseling in general practice. Patient Educ Couns (1994) 1.97
Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology (1990) 1.97
The relative aversiveness of signalled vs unsignalled avoidance. J Exp Anal Behav (1971) 1.96
Derepressed synthesis of cellulase by Cellulomonas. J Bacteriol (1976) 1.94
Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology (2001) 1.94
Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol (2001) 1.91
Quantitative functional measures in MS: what is a reliable change? Neurology (2002) 1.81
Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer (2008) 1.78
Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord (2000) 1.78
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology (2012) 1.77
Air pollution and daily mortality in Sydney, Australia, 1989 through 1993. Am J Public Health (1998) 1.75
Continuing education for pharmacists and general practitioners. Br J Gen Pract (1991) 1.75
Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology (2008) 1.70
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1. Neurology (2010) 1.67
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65
Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit Care Med (2001) 1.65
Cross-linking of IgE-receptor complexes at the cell surface: a fluorescence method for studying the binding of monovalent and bivalent haptens to IgE. Mol Immunol (1986) 1.65
Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology (2010) 1.63
Improved techniques for kidney transplantation in mice. Microsurgery (1995) 1.63
Kinetics of light-sensitive channels in vertebrate photoreceptors. Proc R Soc Lond B Biol Sci (1985) 1.59
Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology (2006) 1.57
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro. J Virol (2005) 1.53
Mutation of an arginine biosynthesis gene causes reduced pathogenicity in Fusarium oxysporum f. sp. melonis. Mol Plant Microbe Interact (2001) 1.50
Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages. J Biol Chem (1990) 1.48
Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody. Biophys J (1989) 1.47
Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis. Br J Dermatol (2013) 1.47
Prospective study of genetic counselling. Br Med J (1979) 1.47
John Hunter's practice. Ann R Coll Surg Engl (1966) 1.47
Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci U S A (2001) 1.46
Clean intermittent self-catheterisation in the management of adult lower urinary tract dysfunction. Br J Urol (1984) 1.45
The structure and formation of the byssus attachment plaque in Mytilus. J Morphol (1976) 1.45
1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.45
Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment. Neurology (2003) 1.44
Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet (2001) 1.43
Cognitive development and dietary therapy in phenylketonuric children. N Engl J Med (1968) 1.42
Hypernatremic dehydration in a neonate. Indian Pediatr (2001) 1.42
Museum specimens of the main superficial and deep lymphatics of the leg in man. Ann R Coll Surg Engl (1968) 1.42
A multiple sclerosis cluster associated with a small, north-central Illinois community. Arch Environ Health (2002) 1.41
ALS defeats gabapentin: reflections on another failed treatment. Neurology (2001) 1.41
Analysis of single-cell differences by use of an on-chip microculture system and optical trapping. Fresenius J Anal Chem (2001) 1.41
A novel magnetic approach to enhance the efficacy of cell-based gene therapies. Gene Ther (2008) 1.40
Negative reinforcement with shock-frequency increase. J Exp Anal Behav (1976) 1.40
Current practice of transthoracic endoscopic sympathectomy in the south west of England: an e-mail survey. Eur J Vasc Endovasc Surg (2001) 1.40
The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer (1996) 1.40
Outcomes of weight-based heparin dosing based on literature guidelines and institution individualization. Pharmacotherapy (2000) 1.39
Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology (2007) 1.38
Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain. J Biol Chem (1993) 1.38
Mountain sickness, retinal haemorrhages, and acclimatisation on Mount Everest in 1975. Br Med J (1976) 1.37
Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology (2009) 1.37
High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol (1997) 1.36
Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation (1988) 1.36
Pressure dependence of sodium gating currents in the squid giant axon. Eur Biophys J (1984) 1.36
Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab (1999) 1.35
Percivall Pott. Ann R Coll Surg Engl (1972) 1.34
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Antimicrob Agents Chemother (1993) 1.33
Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group. Phys Ther (1994) 1.33
Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res (2001) 1.33
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 1.32
Prevalence of tics in schoolchildren and association with placement in special education. Neurology (2001) 1.32
Preference for signalled reinforcement. J Exp Anal Behav (1974) 1.32
Molecular cloning of a novel brain-type Na(+)-dependent inorganic phosphate cotransporter. J Neurochem (2000) 1.29
The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol (1995) 1.29